Quest Diagnostics Incorporated (DGX) stock analysis
Healthcare · Diagnostics & Research
From the 10-K filed 2026-02-26
How it makes money
Quest Diagnostics generates net revenues by providing diagnostic testing insights and services across various healthcare channels.
Quest Diagnostics serves a large portion of the United States adult population annually, providing laboratory testing and diagnostic insights to physicians, hospitals, patients, and other healthcare entities. Revenue is driven by the volume and pricing of diagnostic tests ordered by healthcare providers or initiated directly by consumers.
Net revenues reached $11.0 billion during 2025. The company operates through primary customer channels including physicians, hospitals, and direct-to-consumer offerings, leveraging its national scale, comprehensive test menu, and data assets.
What protects it: the moat
Management claims differentiation through scale, an extensive test menu, data assets, and proprietary operational management systems.
The company competes in a fragmented and highly competitive clinical testing industry against other commercial laboratories, hospital-affiliated laboratories, and physician-office laboratories. Management asserts that its competitive position relies on providing high quality, innovative, convenient, and affordable services.
Additional defensive layers include proprietary tools like the Quest Management System, advanced diagnostics offerings, and extensive distribution networks that standardize services on a national or regional scale.
What growth costs
The filing does not specify the exact capital expenditures required to maintain and grow earnings.
The text mentions that Quest Diagnostics drives growth by offering an industry-leading test menu, collaborating with healthcare providers, leveraging data assets, and continuously improving quality and efficiency through automation and artificial intelligence. However, the filing provides no explicit monetary figures for maintaining versus growing these capabilities.
What could damage it
Increased hospital acquisition of physician practices could redirect test referrals away from Quest toward hospital-owned laboratories, reducing revenues.
Hospitals frequently maintain on-site laboratories and compete for outreach testing from non-hospital patients. When hospitals acquire physician practices, they can encourage or require those practices to refer testing to the hospital's internal laboratory rather than a commercial provider like Quest, thereby eroding the customer base and pricing power.
About Quest Diagnostics Incorporated
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; healthcare IT healthcare providers and payers; testing and medical director services at hospital laboratories; test offerings in cardiometabolic and endocrine; cancer; clinical drug monitoring and toxicology; infectious disease, including autoimmune; neurology diagnostics, including Alzheimer's disease; and women's health, such as prenatal genetic; workplace drug testing, testing urine, hair, and oral fluid specimens services; and employer population health services, including biometric screenings, flu shots, and related preventative services. Further, it provides population health solutions; extended care services; develops in vitro diagnostic tests; laboratory diagnostic information and digital health connectivity systems; underwriting support services, including data gathering, paramedical examinations, and clinical laboratory testing and analytics; and national specimen collection and health data solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.